Dabigatran in Patients With Nonvalvular Atrial Fibrillation

被引：3
|
作者：
Gage, Lawrence [1 ]
机构：
[1] Rochester Gen Hosp, Rochester Cardiopulm Grp, PC, Rochester, NY 14621 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2011年 / 58卷 / 05期
关键词：
D O I：
10.1016/j.jacc.2011.04.016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：551 / 551
页数：1
相关论文
共 50 条
  • [21] Stroke, Bleeding, and Mortality Risks in Older Patients Treated with Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation
    Graham, David J.
    Reichman, Marsha E.
    Wernecke, Michael
    Hsueh, Ya-Hui
    Izem, Rima
    Southworth, Mary Ross
    Wei, Yuqin
    Liao, Jiemin
    Goulding, Margie R.
    Mott, Katrina
    Chillarige, Yoganand
    MaCurdy, Thomas E.
    Worrall, Chris
    Kelman, Jeffrey A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 500 - 501
  • [22] Anticoagulation in patients with nonvalvular atrial fibrillation
    Bosomworth, N. John
    CANADIAN FAMILY PHYSICIAN, 2023, 69 (06) : 381 - 381
  • [23] Economic Evaluation of Percutaneous Left Atrial Appendage Occlusion, Dabigatran, and Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation
    Singh, Sheldon M.
    Micieli, Andrew
    Wijeysundera, Harindra C.
    CIRCULATION, 2013, 127 (24) : 2414 - 2423
  • [24] Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation
    Noseworthy, Peter A.
    Yao, Xiaoxi
    Abraham, Neena S.
    Sangaralingham, Lindsey R.
    McBane, Robert D.
    Shah, Nilay D.
    CHEST, 2016, 150 (06) : 1302 - 1312
  • [25] Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin
    Tetsuya Watanabe
    Yukinori Shinoda
    Kuniyasu Ikeoka
    Hirooki Inui
    Hidetada Fukuoka
    Akihiro Sunaga
    Takashi Kanda
    Masaaki Uematsu
    Shiro Hoshida
    Heart and Vessels, 2017, 32 : 326 - 332
  • [26] Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin
    Watanabe, Tetsuya
    Shinoda, Yukinori
    Ikeoka, Kuniyasu
    Inui, Hirooki
    Fukuoka, Hidetada
    Sunaga, Akihiro
    Kanda, Takashi
    Uematsu, Masaaki
    Hoshida, Shiro
    HEART AND VESSELS, 2017, 32 (03) : 326 - 332
  • [27] Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
    Chan, Yi-Hsin
    See, Lai-Chu
    Tu, Hui-Tzu
    Yeh, Yung-Hsin
    Chang, Shang-Hung
    Wu, Lung-Sheng
    Lee, Hsin-Fu
    Wang, Chun-Li
    Kuo, Chang-Fu
    Kuo, Chi-Tai
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
  • [28] DIRECT COMPARISON OF DABIGATRAN, RIVAROXABAN, AND APIXABAN FOR EFFECTIVENESS AND SAFETY IN NONVALVULAR ATRIAL FIBRILLATION
    Noseworthy, Peter
    Yao, Xiaoxi
    Sangaralingham, Lindsey R.
    Abraham, Neena
    McBane, Robert
    Gersh, Bernard
    Shah, Nilay
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 692 - 692
  • [29] Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation
    Chan, Yi-Hsin
    Kuo, Chi-Tai
    Yeh, Yung-Hsin
    Chang, Shang-Hung
    Wu, Lung-Sheng
    Lee, Hsin-Fu
    Tu, Hui-Tzu
    See, Lai-Chu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (13) : 1389 - 1401
  • [30] Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation
    Adeboyeje, Gboyega
    Sylwestrzak, Gosia
    Barron, John J.
    White, Jeff
    Rosenberg, Alan
    Abarca, Jacob
    Crawford, Geoffrey
    Redberg, Rita
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (09): : 968 - 978
12345